-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Edwards Lifesciences, Lowers Price Target to $75

Benzinga·04/11/2025 13:20:02
Listen to the news
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and lowers the price target from $78 to $75.